IBDEI362 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50562,1,3,0)
;;=3^Polycystic Kidney,Adult Type
;;^UTILITY(U,$J,358.3,50562,1,4,0)
;;=4^Q61.2
;;^UTILITY(U,$J,358.3,50562,2)
;;=^5018796
;;^UTILITY(U,$J,358.3,50563,0)
;;=N41.1^^193^2494^90
;;^UTILITY(U,$J,358.3,50563,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50563,1,3,0)
;;=3^Prostatitis,Chronic
;;^UTILITY(U,$J,358.3,50563,1,4,0)
;;=4^N41.1
;;^UTILITY(U,$J,358.3,50563,2)
;;=^186931
;;^UTILITY(U,$J,358.3,50564,0)
;;=N11.9^^193^2494^98
;;^UTILITY(U,$J,358.3,50564,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50564,1,3,0)
;;=3^Pyelonephritis,Chronic,Unspec
;;^UTILITY(U,$J,358.3,50564,1,4,0)
;;=4^N11.9
;;^UTILITY(U,$J,358.3,50564,2)
;;=^5015574
;;^UTILITY(U,$J,358.3,50565,0)
;;=N20.9^^193^2494^116
;;^UTILITY(U,$J,358.3,50565,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50565,1,3,0)
;;=3^Urinary Calculus,Unspec
;;^UTILITY(U,$J,358.3,50565,1,4,0)
;;=4^N20.9
;;^UTILITY(U,$J,358.3,50565,2)
;;=^5015610
;;^UTILITY(U,$J,358.3,50566,0)
;;=R97.20^^193^2494^29
;;^UTILITY(U,$J,358.3,50566,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50566,1,3,0)
;;=3^Elevated PSA
;;^UTILITY(U,$J,358.3,50566,1,4,0)
;;=4^R97.20
;;^UTILITY(U,$J,358.3,50566,2)
;;=^334262
;;^UTILITY(U,$J,358.3,50567,0)
;;=N52.36^^193^2494^34
;;^UTILITY(U,$J,358.3,50567,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50567,1,3,0)
;;=3^Erectile Dysfunction After Interstitial Seed Therapy
;;^UTILITY(U,$J,358.3,50567,1,4,0)
;;=4^N52.36
;;^UTILITY(U,$J,358.3,50567,2)
;;=^5138933
;;^UTILITY(U,$J,358.3,50568,0)
;;=N52.37^^193^2494^35
;;^UTILITY(U,$J,358.3,50568,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50568,1,3,0)
;;=3^Erectile Dysfunction After Prostate Ablative Therapy
;;^UTILITY(U,$J,358.3,50568,1,4,0)
;;=4^N52.37
;;^UTILITY(U,$J,358.3,50568,2)
;;=^5138934
;;^UTILITY(U,$J,358.3,50569,0)
;;=N52.35^^193^2494^36
;;^UTILITY(U,$J,358.3,50569,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50569,1,3,0)
;;=3^Erectile Dysfunction After Radiation Therapy
;;^UTILITY(U,$J,358.3,50569,1,4,0)
;;=4^N52.35
;;^UTILITY(U,$J,358.3,50569,2)
;;=^5138932
;;^UTILITY(U,$J,358.3,50570,0)
;;=R31.21^^193^2494^56
;;^UTILITY(U,$J,358.3,50570,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50570,1,3,0)
;;=3^Hematuria,Microscopic,Asymptomatic
;;^UTILITY(U,$J,358.3,50570,1,4,0)
;;=4^R31.21
;;^UTILITY(U,$J,358.3,50570,2)
;;=^5139198
;;^UTILITY(U,$J,358.3,50571,0)
;;=R31.29^^193^2494^57
;;^UTILITY(U,$J,358.3,50571,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50571,1,3,0)
;;=3^Hematuria,Microscopic,Other
;;^UTILITY(U,$J,358.3,50571,1,4,0)
;;=4^R31.29
;;^UTILITY(U,$J,358.3,50571,2)
;;=^5019327
;;^UTILITY(U,$J,358.3,50572,0)
;;=R39.198^^193^2494^70
;;^UTILITY(U,$J,358.3,50572,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50572,1,3,0)
;;=3^Micturition,Oth Difficulties
;;^UTILITY(U,$J,358.3,50572,1,4,0)
;;=4^R39.198
;;^UTILITY(U,$J,358.3,50572,2)
;;=^5019347
;;^UTILITY(U,$J,358.3,50573,0)
;;=R39.191^^193^2494^72
;;^UTILITY(U,$J,358.3,50573,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50573,1,3,0)
;;=3^Need to Immediately Re-Void
;;^UTILITY(U,$J,358.3,50573,1,4,0)
;;=4^R39.191
;;^UTILITY(U,$J,358.3,50573,2)
;;=^5139199
;;^UTILITY(U,$J,358.3,50574,0)
;;=R39.192^^193^2494^71
;;^UTILITY(U,$J,358.3,50574,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50574,1,3,0)
;;=3^Micturition,Position Dependent
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI362 3763 printed Dec 13, 2024@02:42:31 Page 2
IBDEI362 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50562,1,3,0)
+2 ;;=3^Polycystic Kidney,Adult Type
+3 ;;^UTILITY(U,$J,358.3,50562,1,4,0)
+4 ;;=4^Q61.2
+5 ;;^UTILITY(U,$J,358.3,50562,2)
+6 ;;=^5018796
+7 ;;^UTILITY(U,$J,358.3,50563,0)
+8 ;;=N41.1^^193^2494^90
+9 ;;^UTILITY(U,$J,358.3,50563,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,50563,1,3,0)
+12 ;;=3^Prostatitis,Chronic
+13 ;;^UTILITY(U,$J,358.3,50563,1,4,0)
+14 ;;=4^N41.1
+15 ;;^UTILITY(U,$J,358.3,50563,2)
+16 ;;=^186931
+17 ;;^UTILITY(U,$J,358.3,50564,0)
+18 ;;=N11.9^^193^2494^98
+19 ;;^UTILITY(U,$J,358.3,50564,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,50564,1,3,0)
+22 ;;=3^Pyelonephritis,Chronic,Unspec
+23 ;;^UTILITY(U,$J,358.3,50564,1,4,0)
+24 ;;=4^N11.9
+25 ;;^UTILITY(U,$J,358.3,50564,2)
+26 ;;=^5015574
+27 ;;^UTILITY(U,$J,358.3,50565,0)
+28 ;;=N20.9^^193^2494^116
+29 ;;^UTILITY(U,$J,358.3,50565,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,50565,1,3,0)
+32 ;;=3^Urinary Calculus,Unspec
+33 ;;^UTILITY(U,$J,358.3,50565,1,4,0)
+34 ;;=4^N20.9
+35 ;;^UTILITY(U,$J,358.3,50565,2)
+36 ;;=^5015610
+37 ;;^UTILITY(U,$J,358.3,50566,0)
+38 ;;=R97.20^^193^2494^29
+39 ;;^UTILITY(U,$J,358.3,50566,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,50566,1,3,0)
+42 ;;=3^Elevated PSA
+43 ;;^UTILITY(U,$J,358.3,50566,1,4,0)
+44 ;;=4^R97.20
+45 ;;^UTILITY(U,$J,358.3,50566,2)
+46 ;;=^334262
+47 ;;^UTILITY(U,$J,358.3,50567,0)
+48 ;;=N52.36^^193^2494^34
+49 ;;^UTILITY(U,$J,358.3,50567,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,50567,1,3,0)
+52 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
+53 ;;^UTILITY(U,$J,358.3,50567,1,4,0)
+54 ;;=4^N52.36
+55 ;;^UTILITY(U,$J,358.3,50567,2)
+56 ;;=^5138933
+57 ;;^UTILITY(U,$J,358.3,50568,0)
+58 ;;=N52.37^^193^2494^35
+59 ;;^UTILITY(U,$J,358.3,50568,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,50568,1,3,0)
+62 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
+63 ;;^UTILITY(U,$J,358.3,50568,1,4,0)
+64 ;;=4^N52.37
+65 ;;^UTILITY(U,$J,358.3,50568,2)
+66 ;;=^5138934
+67 ;;^UTILITY(U,$J,358.3,50569,0)
+68 ;;=N52.35^^193^2494^36
+69 ;;^UTILITY(U,$J,358.3,50569,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,50569,1,3,0)
+72 ;;=3^Erectile Dysfunction After Radiation Therapy
+73 ;;^UTILITY(U,$J,358.3,50569,1,4,0)
+74 ;;=4^N52.35
+75 ;;^UTILITY(U,$J,358.3,50569,2)
+76 ;;=^5138932
+77 ;;^UTILITY(U,$J,358.3,50570,0)
+78 ;;=R31.21^^193^2494^56
+79 ;;^UTILITY(U,$J,358.3,50570,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,50570,1,3,0)
+82 ;;=3^Hematuria,Microscopic,Asymptomatic
+83 ;;^UTILITY(U,$J,358.3,50570,1,4,0)
+84 ;;=4^R31.21
+85 ;;^UTILITY(U,$J,358.3,50570,2)
+86 ;;=^5139198
+87 ;;^UTILITY(U,$J,358.3,50571,0)
+88 ;;=R31.29^^193^2494^57
+89 ;;^UTILITY(U,$J,358.3,50571,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,50571,1,3,0)
+92 ;;=3^Hematuria,Microscopic,Other
+93 ;;^UTILITY(U,$J,358.3,50571,1,4,0)
+94 ;;=4^R31.29
+95 ;;^UTILITY(U,$J,358.3,50571,2)
+96 ;;=^5019327
+97 ;;^UTILITY(U,$J,358.3,50572,0)
+98 ;;=R39.198^^193^2494^70
+99 ;;^UTILITY(U,$J,358.3,50572,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,50572,1,3,0)
+102 ;;=3^Micturition,Oth Difficulties
+103 ;;^UTILITY(U,$J,358.3,50572,1,4,0)
+104 ;;=4^R39.198
+105 ;;^UTILITY(U,$J,358.3,50572,2)
+106 ;;=^5019347
+107 ;;^UTILITY(U,$J,358.3,50573,0)
+108 ;;=R39.191^^193^2494^72
+109 ;;^UTILITY(U,$J,358.3,50573,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,50573,1,3,0)
+112 ;;=3^Need to Immediately Re-Void
+113 ;;^UTILITY(U,$J,358.3,50573,1,4,0)
+114 ;;=4^R39.191
+115 ;;^UTILITY(U,$J,358.3,50573,2)
+116 ;;=^5139199
+117 ;;^UTILITY(U,$J,358.3,50574,0)
+118 ;;=R39.192^^193^2494^71
+119 ;;^UTILITY(U,$J,358.3,50574,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,50574,1,3,0)
+122 ;;=3^Micturition,Position Dependent
